-
Bank Ranking
Banks Ratios
Cement Statistics
Cement Ranking
Cement Ratios
Monetary and Economic Statistics
Oil, Gas and Fuel
Macro Economy
Consumer Spending
Inflation
Exports & Imports
Food Prices
Non Food Prices
Construction Materials
Petrochem. Ranking
Petrochem. Ratios
Retail Rankings
Retail Ratios
Grocery Ranking
Grocery Ratios
Top Growth
Dividend History
Equipment House profit drops 35% to SAR 26.1M; Q4 loss at SAR 1.2M
Scientific and Medical Equipment House Co. (Equipment House) reported a net profit of SAR 26.1 million, after deducting minority interest, in 2024, a 35% decline compared to SAR 40.1 million in 2023.
Financials (M)
| Item | 2023 | 2024 | Change |
|---|---|---|---|
| Revenues | 776.67 | 877.23 | 12.9 % |
| Gross Income | 129.16 | 133.59 | 3.4 % |
| Operating Income | 77.08 | 57.54 | (25.4 %) |
| Net Income | 40.06 | 26.17 | (34.7 %) |
| Average Shares | 30.00 | 30.00 | - |
| Earnings Per Share before unusual items | 1.34 | 1.09 | (18.1 %) |
| EPS (Riyals) | 1.34 | 0.87 | (34.7 %) |
Net profit decreased due to a reversal of the previous year's provision for expected credit losses of SAR 21.5 million, compared to the current year's reversal of SAR 4.6 million. This reversal was based on the risk ratios associated with historical debt collection events and future expectations.
Gross profit also decreased by 2% year-on-year (YoY) due to higher operating costs such as salaries and wages of medical staff and higher project costs for labor and subcontractors.
Meanwhile, the company reported an 11% increase in revenue of operation and supply divisions due to the commencement of several new projects in the sub-divisions of non-medical operations, catering sectors and biomedical maintenance.
It also cited a 24% increase in the contracting segment due to higher completion rates of projects and a 24% increase in sales of the medical devices and equipment division.
Current Quarter Comparison (M)
| Item | Q4 2023 | Q4 2024 | Change |
|---|---|---|---|
| Revenues | 229.97 | 227.23 | (1.2 %) |
| Gross Income | 36.65 | 26.51 | (27.7 %) |
| Operating Income | 26.81 | 5.54 | (79.3 %) |
| Net Income | 13.59 | (1.17) | (108.6 %) |
| Average Shares | 30.00 | 30.00 | - |
| Earnings Per Share before unusual items | 0.45 | (0.08) | (118.7 %) |
| EPS (Riyals) | 0.45 | (0.04) | (108.6 %) |
The company incurred SAR 1.2 million losses in Q4 2024 versus SAR 13.59 million profit in Q4 2023.
Sequentially, Equipment House turned to a loss from SAR 10.9 million profit in Q3 2024.
Total shareholders’ equity, excluding minority interest, stood at SAR 510 million by Dec. 31, 2024, compared to SAR 507 million a year earlier.
View other reports
Share Price
Scientific and Medical Equipment House Co. (EQUIPMENT HOUSE)
| Current | |
| Market Cap (M Riyal) | 1,222.50 |
| Enterprise Value (EV) (M) | 1,322.28 |
| Shares Outstanding ((M)) | 30.00 |
| EPS ( Riyal) (TTM) | 0.87 |
| Book Value (BV) ( Riyal) | 17.02 |
| Par Value ( Riyal) | 10.00 |
| Adjusted P/E (Last12) | 49.30 |
| P/E (TTM) | 46.72 |
| Price/book | 2.39 |
| Return on Average Assets (%) (TTM) | 2.5 |
| Return on Average Equity (%) (TTM) | 3.2 |
Financial results (Million)
| Period | Revenues | Change | Gross Income | Change | Operating Income | Change |
|---|---|---|---|---|---|---|
| Q1 2024 | 217.76 | 32.0 % | 37.74 | 22.2 % | 15.53 | 26.3 % |
| Q2 2024 | 215.40 | 12.9 % | 34.90 | 16.8 % | 17.60 | 112.9 % |
| Q3 2024 | 218.39 | 5.7 % | 34.78 | (2.3 %) | 17.32 | (35.2 %) |
| Q4 2024 | 227.23 | (1.2 %) | 26.51 | (27.7 %) | 5.54 | (79.3 %) |
| 2024 | 877.23 | 12.9 % | 133.59 | 3.4 % | 57.54 | (25.4 %) |
Profit Performance (Million)
| Period | Net Income | Change | EPS(Riyal) | Extraordinary Income/Expense | Net Profit Before Unusual Items | Earnings Per Share before unusual items |
|---|---|---|---|---|---|---|
| Q1 2024 | 8.77 | 27.8 % | 0.29 | - | 8.77 | 0.29 |
| Q2 2024 | 7.66 | 295.0 % | 0.26 | - | 7.66 | 0.26 |
| Q3 2024 | 10.91 | (38.3 %) | 0.36 | - | 10.91 | 0.36 |
| Q4 2024 | (1.17) | (108.6 %) | (0.04) | 1.37 | (2.54) | (0.08) |
| 2024 | 26.17 | (34.7 %) | 0.87 | (6.63) | 32.79 | 1.09 |
Profitability
| Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
|---|---|---|---|
| Q1 2024 | 16.55 % | 11.79 % | 4.97 % |
| Q2 2024 | 16.66 % | 12.44 % | 5.48 % |
| Q3 2024 | 16.34 % | 11.05 % | 4.64 % |
| Q4 2024 | 15.24 % | 8.60 % | 2.82 % |
| 2024 | 15.23 % | 8.79 % | 3.74 % |
Per Share Data (Riyal)
| Period | Shares Outstanding (M) | EPS (Riyal) | Earnings Per Share before unusual items (Riyal) | Book Value (BV) |
|---|---|---|---|---|
| Q1 2024 | 30.00 | 1.40 | 1.40 | 17.32 |
| Q2 2024 | 30.00 | 1.59 | 1.59 | 17.57 |
| Q3 2024 | 30.00 | 1.36 | 1.36 | 17.94 |
| Q4 2024 | 30.00 | 0.87 | 0.83 | 17.02 |
Multiple Ratios (End of Period Price)
| Period | P/E | Adjusted P/E | Price/book |
|---|---|---|---|
| Q1 2024 | 37.82 | 37.82 | 3.05 |
| Q2 2024 | 32.34 | 32.34 | 2.92 |
| Q3 2024 | 40.97 | 40.97 | 3.12 |
| Q4 2024 | 57.89 | 61.09 | 2.97 |
Business Segments (Million)
Q4 2024
| Period | Operation and maintenance | Sales of medical devices and revenue from after-sales maintenance services | Construction | Medications and Medical Supplies | Meat and Food | Eliminations |
|---|---|---|---|---|---|---|
| Q1 2024 | 178.91 | 22.31 | 11.94 | 4.02 | 4.93 | (4.35) |
| Q2 2024 | 183.30 | 19.83 | 12.86 | 2.75 | 3.04 | (4.97) |
| Q3 2024 | 188.70 | 20.91 | 11.16 | 1.34 | 2.99 | (6.70) |
| Q4 2024 | 187.78 | 17.85 | 19.80 | 1.57 | 7.31 | (7.07) |
Analysts Estimates (Million)
| Item | Q4 2024 (e) | Q4 2024 (net income) | Change |
|---|---|---|---|
| Average | 11.00 | (1.17) | (110.6 %) |
Estimates vs Actual (Million)
| Item | Q4 2024 (e) | Q4 2024 (net income) | Change |
|---|---|---|---|
| Al Rajhi Capital | 11.00 | (1.17) | (110.6) % |
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}